Skip To Main Content
Chiarion Sileni V on Muck Rack

Chiarion Sileni V

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chiarion

Contact Chiarion, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study. (pdf) | Paperity

|
By P. Quaglino, G. Rinaldi, Del Vecchio M, Chiarion Sileni V
| paperity.org
Dermatology Practical & Conceptual, Mar 2023 This is a preview of a remote PDF: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093702/pdf/ Del Vecchio M., Chiarion Sileni V., P. Quaglino, G. Rinaldi, A. Minisini, T. Troiani, F. Consoli, A. Sponghini, M. Banzi, M. Morelli, D. Palleschi, E. Rossi, R. Marconcini, R. Depenni, F. Carnevale-Schianca, I. Marcon, P. Queirolo. , Dermatology Practical & Conceptual, 2023, Volume 15, Issue 7, DOI: 10.3390/cancers15071980
Open in Who Shared Issue with article?
See all 1 articles